Recombinant Vaccinia Virus

· Jennerex Biotherapeutics

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Recombinant Vaccinia Virus, covering 2016-01-08 to 2026-07-27. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma [Phase 1, Phase 2]